1. Home
  2. TRUP vs ANIP Comparison

TRUP vs ANIP Comparison

Compare TRUP & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUP
  • ANIP
  • Stock Information
  • Founded
  • TRUP 2000
  • ANIP 2001
  • Country
  • TRUP United States
  • ANIP United States
  • Employees
  • TRUP N/A
  • ANIP N/A
  • Industry
  • TRUP Medical Specialities
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUP Health Care
  • ANIP Health Care
  • Exchange
  • TRUP Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • TRUP 1.9B
  • ANIP 2.0B
  • IPO Year
  • TRUP 2014
  • ANIP N/A
  • Fundamental
  • Price
  • TRUP $42.58
  • ANIP $90.89
  • Analyst Decision
  • TRUP Buy
  • ANIP Strong Buy
  • Analyst Count
  • TRUP 4
  • ANIP 8
  • Target Price
  • TRUP $55.50
  • ANIP $93.63
  • AVG Volume (30 Days)
  • TRUP 401.4K
  • ANIP 326.2K
  • Earning Date
  • TRUP 10-29-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • TRUP N/A
  • ANIP N/A
  • EPS Growth
  • TRUP N/A
  • ANIP N/A
  • EPS
  • TRUP 0.25
  • ANIP N/A
  • Revenue
  • TRUP $1,360,295,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • TRUP $13.17
  • ANIP $39.36
  • Revenue Next Year
  • TRUP $7.63
  • ANIP $9.45
  • P/E Ratio
  • TRUP $168.08
  • ANIP N/A
  • Revenue Growth
  • TRUP 13.11
  • ANIP 38.68
  • 52 Week Low
  • TRUP $31.00
  • ANIP $52.50
  • 52 Week High
  • TRUP $57.90
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • TRUP 39.46
  • ANIP 46.49
  • Support Level
  • TRUP $41.52
  • ANIP $88.19
  • Resistance Level
  • TRUP $43.82
  • ANIP $92.52
  • Average True Range (ATR)
  • TRUP 1.31
  • ANIP 2.59
  • MACD
  • TRUP 0.03
  • ANIP -1.05
  • Stochastic Oscillator
  • TRUP 27.83
  • ANIP 25.72

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: